Explore › Intervention › Targeted glucose and metabolic screening
Intervention

Targeted glucose and metabolic screening

Also known as: Targeted glucose and metabolic screening in women with prior SGA birth history
3 findings 1 paper 4 related entities View in graph →

Related entities

conditions
Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome1
outcomes
Glucose Metabolism Disorders1
populations
Postmenopausal Women1
studys
PMC30744071

Findings (27)

None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →

Papers (1)